This content is restricted.
Brief
The Commission Implementing Regulation (EU) 2024/2563 amends Implementing Regulation (EU) 2022/1646 to add content to national risk-based control plans and randomised surveillance plans. The regulation requires Member States to specify species, sampling places, and national legislation on pharmacologically active substances in the plans. The amendment aims to ensure consistency and clarity in the submission of control plans and data by Member States. It modifies the heading of Article 8 and replaces Article 7 with a new provision specifying additional content for the national risk-based control plans and randomised surveillance plan.
Highlights content goes here...
This content is restricted.
